11th Digital Pathology & AI Congress: Europe
This internationally recognised meeting is the only meeting truly focused on the transformative power of Digital Pathology and the advances created by Artificial Intelligence and Machine Learning. Across the health sector and pharmaceutical/biotech industry the adoption of digital pathology is speeding up. It’s impact is being felt in primary diagnosis and clinical research as well as the laboratory.
Realisable benefits include:
1. Enhanced Diagnostic Accuracy
2. Increased Workflow Efficiency
3. Accelerated Drug Discovery
4. Improved Patient Outcomes
5. Cost Savings
No wonder health services are implementing digital pathology to improve diagnostic services and patient outcomes particularly for better cancer diagnostics and treatment planning. While research institutions and pharmaceutical companies are leveraging AI to accelerate drug discovery and development, leading to more innovative treatments reaching the market faster.
The head of the Medical Image Area at TIC Salut Social Foundation, Elisenda Reixach, will present the poster ‘Connecting the dots: Building blocks to deploy a Digital Pathology Network in Catalonia‘.
